Children, young people, and adults across England suffering from sickle cell disease will soon benefit from better care closer to where they live, following the announcement of a £1.5m investment in 25 red blood cell exchange devices. Funding for the Spectra Optia(R) Apheresis System devices has been distributed to 22 NHS trusts, with the devices […]
Read More… from Sickle cell patients to benefit from £1.5m technology investment from NHS England